Thank you.
I will look into Canada's regime and get back to the committee with an answer.
What I was talking about was a pooled procurement mechanism, not a pool of medicines contributed by donor or non-donor countries. Through the mechanism, the Global Fund is able to proactively negotiate with labs and suppliers of the various health products we need. Those products are then made available to countries in accordance with their requests. Countries determine their own needs. The Global Fund uses a funding mechanism based on each country's own priorities in combatting the three diseases. Countries seek out use of the mechanism, and we provide them with the medicines requested. It's not a pool of donated medicines. Rather, it's a pooled procurement framework to negotiate better prices for high-quality drugs.
I hope that answers your question, Mr. Bergeron.